Large gap with delayed quotes
|
Last quote
12/27/2024 -
17:35:25
|
Bid
12/27/2024 -
17:30:00
|
Bid Volume |
Ask
12/27/2024 -
17:29:59
|
Ask Volume |
|---|---|---|---|---|
|
135.90
-1.60
(
-1.16% )
|
135.80
|
74 |
136.00
|
35 |
Analysis date: 24.12.2024
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 12.11.2024.
Interest
Weak
Weak
Weak interest since 17.12.2024.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 13.12.2024 at a price of 150.30.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 17.12.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
-5.49%
-5.49%
The four week relative underperformance versus STOXX600 is 5.49%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 02.07.2024.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.79%.
Mkt Cap in $bn
2.91
2.91
With a market capitalization between $2 & $8bn, REDCARE PHARMACY is considered a mid-cap stock.
G/PE Ratio
3.59
3.59
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
54.61
54.61
The estimated PE is for the year 2026.
LT Growth
196.05%
196.05%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
110
110
For 1% of index variation, the stock varies on average by 1.10%.
Correlation
0.21
0.21
Stock movements are strongly independent of index variations.
Value at Risk
28.96
28.96
The value at risk is estimated at EUR 28.96. The risk is therefore 21.06%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
03.11.2017
03.11.2017